artesunic acid has been researched along with Metastase in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ateeq, B; Goel, S; Nunes, JJ; Pandey, SK; Yadav, A | 1 |
| Edler, L; Efferth, T; Elsässer, M; Goeckenjan, M; Munzinger, J; Osburg, J; Remppis, BA; Schneeweiss, A; Sertel, S; Storch-Hagenlocher, B; Strowitzki, T; von Hagens, C; Walter-Sack, I | 1 |
| Choi, HY; Jeon, SS; Jeong, BC; Jeong, DE; Joo, KM; Lee, HW; Lee, SJ; Lim, JE; Lim, S; Nam, DH; Song, HJ | 1 |
| Efferth, T; Michaelsen, FW; Saeed, ME; Schwarzkopf, J | 1 |
| Baumann, I; Edler, L; Hoth, S; König, M; Sertel, S; von Hagens, C; Walter-Sack, I | 1 |
| Hu, M; Li, F; Liu, W; Liu, Y; Liu, Z; Lu, L; Ou, R; Tong, Y; Wu, J; Zhang, G; Zheng, H; Zheng, L | 1 |
| Allgayer, H; Asangani, IA; Efferth, T; Rasheed, SA | 1 |
2 trial(s) available for artesunic acid and Metastase
| Article | Year |
|---|---|
Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2).
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Artemisinins; Artesunate; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Maximum Tolerated Dose; Middle Aged; Neoplasm Metastasis; Prospective Studies; Treatment Outcome | 2017 |
Investigation of ototoxicity of artesunate as add-on therapy in patients with metastatic or locally advanced breast cancer: new audiological results from a prospective, open, uncontrolled, monocentric phase I study.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Audiometry; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Treatment Outcome; Vertigo | 2016 |
5 other study(ies) available for artesunic acid and Metastase
| Article | Year |
|---|---|
Targeting NF-kappa B Signaling by Artesunate Restores Sensitivity of Castrate-Resistant Prostate Cancer Cells to Antiandrogens.
Topics: Androgen Receptor Antagonists; Animals; Antineoplastic Agents; Apoptosis; Artemisinins; Artesunate; Caspase 3; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Resistance, Neoplasm; Humans; Male; Mice; Neoplasm Metastasis; NF-kappa B; Oxidative Stress; Phosphorylation; Poly(ADP-ribose) Polymerases; Prostatic Neoplasms, Castration-Resistant; Proteolysis; Signal Transduction; Tumor Burden; Ubiquitin; Xenograft Model Antitumor Assays | 2017 |
Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis.
Topics: Animals; Antigens, CD; Antimalarials; Antineoplastic Agents; Artemisinins; Artesunate; Carcinoma, Renal Cell; Cell Death; Cell Line, Tumor; Cell Proliferation; Female; Human Umbilical Vein Endothelial Cells; Humans; Kidney Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neoplasm Metastasis; Neovascularization, Pathologic; Prognosis; Reactive Oxygen Species; Receptors, Transferrin; Xenograft Model Antitumor Assays | 2015 |
Activity of Artemisia annua and artemisinin derivatives, in prostate carcinoma.
Topics: Aged, 80 and over; Artemisia annua; Artemisinins; Artesunate; Biomarkers, Tumor; Bone Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Immunohistochemistry; Male; Neoplasm Metastasis; Prostate-Specific Antigen; Prostatic Neoplasms | 2015 |
Artemisinin and its derivatives can significantly inhibit lung tumorigenesis and tumor metastasis through Wnt/β-catenin signaling.
Topics: A549 Cells; Animals; Antimalarials; Artemisinins; Artesunate; beta Catenin; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Female; Humans; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; RNA Interference; Wnt Signaling Pathway; Xenograft Model Antitumor Assays | 2016 |
First evidence that the antimalarial drug artesunate inhibits invasion and in vivo metastasis in lung cancer by targeting essential extracellular proteases.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Chick Embryo; Enzyme-Linked Immunosorbent Assay; Gene Expression Profiling; Humans; Lung Neoplasms; Matrix Metalloproteinases; Neoplasm Invasiveness; Neoplasm Metastasis; Polymerase Chain Reaction; RNA, Messenger; Urokinase-Type Plasminogen Activator | 2010 |